CLDN6 and breast cancer: Osanai et al (92) showed increased resistance to apoptosis after CLDN6 knockdown in breast cancer MCF-7 cells, supporting the hypothesis that CLDN6 downregulation could lead to breast cancer tumor formation, and suggesting that the CLDN6 methylation phenotype may contribute to tumor formation and invasion.